Study of an experimental knee injection for osteoarthritis pain
Part of Bones, joints & muscles clinical trials.
This study tests a new investigational medicine injected into the knee to see if it is safe and tolerable for people with painful knee osteoarthritis. It may help reduce pain and improve knee function.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are between 45 and 80 years old.
- You have had knee pain from osteoarthritis for at least 12 months.
- You have had knee pain on more than 15 days in the last month.
- You have tried at least two treatments (like exercise, physical therapy, or anti-inflammatory pills) that did not help enough.
- Your body mass index (BMI) is 40 or less.
- You have moderate to severe knee pain (score of 5 to 9 on a 0-10 scale).
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study tests an experimental injection called GNSC-001 given directly into the knee to see if it can reduce pain and improve knee function in people with knee osteoarthritis. If you join, you'll have one injection and then be followed for a year, and you'll need to stop your usual knee pain medicines during the study.
This study compares two knee injection treatments for knee osteoarthritis. It aims to see which one works better for reducing pain and improving function, so you might experience less knee pain and better mobility.
This study tests a single injection of PTP-001 (MOTYS™) into the knee to see if it reduces osteoarthritis pain. It is for people whose knee pain is their main pain problem and who haven't found relief from standard pain medicines.
This study tests a new knee injection called CX-011 to see if it can reduce pain and improve function in people with knee osteoarthritis. It may be a good option if you have tried other treatments without enough relief.
This study tests a new injection for knee osteoarthritis that aims to improve pain and function. It may help if you have moderate to severe knee pain that hasn't been relieved by first-line treatments.
This trial tests a new knee injection called MAG200. It may reduce knee pain and make daily activities easier.
Hear when a new Osteoarthritis (OA) of the Knee trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.